GSPCROP
GSP Crop Science share price & financials
- Price
- ₹492.2
- Market cap
- ₹2.7k Cr
- Sector
- Chemicals
- Calls analysed
- 2
GSP Crop Science Limited Q1 FY27
What went well
- Revenue grew to ₹386 crores in Q1 FY27, a 2.39% increase YoY, driven by strong domestic business momentum.
- PAT increased by 16% to ₹26.4 crores, supported by improved gross margins from a shift towards specialty and differentiated products.
- Gross margins improved due to a favorable product mix, focusing on higher-margin specialty products.
What to watch
- Revenue growth of 2.39% YoY is modest, with international business partly offset by temporary raw material constraints.
- PAT growth of 16% was significantly influenced by a one-time other income of ₹5.7 crores from a land sale, without which PBT would have been roughly flat YoY.
What GSP Crop Science Limited does
GSP Crop Science manufactures agrochemical technicals (active ingredients), formulations and intermediates — insecticides, herbicides, fungicides and plant growth regulators — across five manufacturing facilities in India. It reaches customers through domestic B2B supply of technicals and formulations, a domestic B2C branded business routed through a distributor network across 23 Indian states, and exports of registered technical and formulation products to 37 countries including Brazil, the USA and African markets. The company runs an in-house R&D and patent programme and indigenously manufactures several patented technical-formulation combinations, some of which it also white-labels for co-marketing partners.
Segments
- Domestic B2B
- Domestic B2C
- Exports
- Manufacturing facilities
- 5 (Odhav, Kathwada, Nandesari, Samba, Saykha)
- Installed formulation capacity
- 43,672 MT/year (Odhav, Kathwada, Samba)
- Installed technical (active ingredient) capacity
- 15,120 MT/year (Odhav, Nandesari)
- Installed intermediates capacity
- 5,400 MT/year (Saykha)
- Domestic distributor network
- ~5,000 distributors
- Indian states covered
- 23 states
Guidance record · Q1 FY27
what the last two calls moved 14 tracked 0 delivered 1 missed 13 open- Revenue at Peak Capacity Utilization went quiet said Q3 FY26 Promised: ₹1,900-2,000 crores Q1 FY27: The peak revenue potential figure was not mentioned this quarter. Management confirmed technical capacity utilization is at 70-75%, with scope to grow.
- Overall Growth Rate revised down said Q3 FY26 Promised: 5-7% higher than last 3 years' growth rate for the upcoming 3 years Q1 FY27: Management provided new, specific guidance of 'around 15%' revenue growth. This is lower than the previous target, which implied a growth rate of 20-22% (based on a historical rate of ~15% + 5-7%).
- Patented Products Revenue Contribution on track said Q3 FY26 Promised: 40-50% in next 3 years Q1 FY27: Management reiterated the goal, stating a target to 'almost double' the patented product share over the next 3 years, which aligns with the original 40% target from a 20% base.
All 14 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 2.4%, net profit up 13.0% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Revenue | 276 | 308 | 377 | 467 | 270 −2% | 402 +31% | 386 +2% |
| EBITDA | 3 | 40 | 42 | 93 | 13 +333% | 36 −10% | 43 +2% |
| Net profit | -6 | 22 | 23 | 58 | -6 +0% | 20 −9% | 26 +13% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +32.3% YTD
YTD: ₹356.25 on 24 Mar 2026 → ₹471.25. High ₹643.15 (26 Aug 2026), low ₹337.9 (30 Mar 2026).
How the price took the results
close before → close after
- Q1 FY27
- −0.6%
- 12 Aug
- Q3 FY26
- +4.2%
- 17 Apr
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
| Year ending | FY26 |
|---|---|
| Revenue | ₹1.5k Cr |
| Operating profit | ₹184 Cr |
| Operating margin | 12.1% |
| Interest | ₹37 Cr |
| Depreciation | ₹30 Cr |
| Net profit | ₹95 Cr |
| Net margin | 6.3% |
| ROCE | 19.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹29 Cr | ₹29 Cr | ₹27 Cr | ₹26 Cr | ₹39 Cr | ₹47 Cr |
| Reserves | ₹366 Cr | ₹439 Cr | ₹336 Cr | ₹344 Cr | ₹491 Cr | ₹725 Cr |
| Borrowings | ₹139 Cr | ₹320 Cr | ₹324 Cr | ₹235 Cr | ₹323 Cr | ₹262 Cr |
| Other liabilities | ₹383 Cr | ₹466 Cr | ₹444 Cr | ₹374 Cr | ₹639 Cr | ₹513 Cr |
| Total liabilities | ₹918 Cr | ₹1.3k Cr | ₹1.1k Cr | ₹980 Cr | ₹1.5k Cr | ₹1.5k Cr |
| Fixed assets | ₹161 Cr | ₹166 Cr | ₹169 Cr | ₹177 Cr | ₹240 Cr | ₹247 Cr |
| Capital work in progress | ₹9 Cr | ₹11 Cr | ₹16 Cr | ₹51 Cr | ₹40 Cr | ₹48 Cr |
| Investments | ₹0 Cr | ₹2 Cr | ₹3 Cr | ₹8 Cr | ₹19 Cr | ₹16 Cr |
| Other assets | ₹747 Cr | ₹1.1k Cr | ₹945 Cr | ₹745 Cr | ₹1.2k Cr | ₹1.2k Cr |
| Total assets | ₹918 Cr | ₹1.3k Cr | ₹1.1k Cr | ₹980 Cr | ₹1.5k Cr | ₹1.5k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Mar 2026, the public added +4.95 pp while DIIs trimmed −2.59 pp. The shareholder count shrank 7% to 7,876.
- Promoters
- 71.7%
- FIIs
- 9.2%
- DIIs
- 0.4%
- Public
- 18.7%
Since Mar 2026
- Public +4.95 pp
- DIIs −2.59 pp
- FIIs −2.35 pp
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Falguni Kenal Shah (Trustee of Kappa Trust) newly disclosed 19.18% held
- Bhavesh Vrajmohan Shah (Trustee of Alpha Trust) newly disclosed 10.44% held
- Deepa Bhavesh Shah (Trustee of Stamford Trust) newly disclosed 4.30% held
- Affluence Fincon Service Private Limited newly disclosed 3.05% held
- Deepa Bhavesh Shah (Trustee of Beta Trust ) newly disclosed 1.81% held
- Psl Limited newly disclosed 1.14% held
- Falguni Kenal Shah (Trustee of Shard Trust) newly disclosed 0.16% held
- Deepa Bhavesh Shah (Trustee of Athena Trust ) newly disclosed 0.16% held
The same filing shows 3 holders trimming and 8 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of GSP Crop Science Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Falguni Kenal Shah (Trustee of Kappa Trust) | 19.18% | newly disclosed |
| Shah Bhavesh Vrajmohan | 17.27% | unchanged |
| Shah Vilasben Vrajmohan | 14.00% | unchanged |
| Bhavesh Vrajmohan Shah (Trustee of Alpha Trust) | 10.44% | newly disclosed |
| Shah Tirth | 4.31% | unchanged |
| Deepa Bhavesh Shah (Trustee of Stamford Trust) | 4.30% | newly disclosed |
| Craft Emerging Market Fund Pcc-Citadel Capital Fund FPI fund | 3.06% | −0.39 pp |
| Affluence Fincon Service Private Limited | 3.05% | newly disclosed |
| Craft Emerging Market Fund Pcc- Elite Capital Fund FPI fund | 2.80% | unchanged |
| Deepa Bhavesh Shah (Trustee of Beta Trust ) | 1.81% | newly disclosed |
| Maybank Securities Pte Ltd - Odi FPI fund | 1.67% | −1.01 pp |
| Shine Star Build Cap Pvt Ltd NBFC / DFI | 1.34% | −1.35 pp |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
All earnings calls (2)
Read the Q1 FY27 call →Learn to analyse GSP Crop Science Limited
Guides on how to read this kind of business and the numbers that matter.